IUI can work well for women with PCOS, and it’s one of the most common treatments offered after oral medications alone haven’t led to pregnancy. Cumulative live birth rates reach about 31% after three to four cycles, with roughly 98% of IUI pregnancies occurring within the first three cycles. Those numbers make IUI a reasonable middle step between ovulation induction with timed intercourse and IVF.
Why IUI Helps With PCOS Specifically
The core fertility problem in PCOS is irregular or absent ovulation. Your ovaries contain plenty of eggs, but hormonal imbalances prevent them from maturing and releasing on a predictable schedule. IUI addresses this by pairing ovulation-inducing medication with a precisely timed procedure that places concentrated, washed sperm directly into the uterus, bypassing the cervix entirely.
This combination solves two problems at once. The medication forces a mature egg to develop and release, and the insemination shortens the distance sperm need to travel, improving the odds that sperm and egg meet during the narrow window of fertility. For couples where the woman has PCOS and the male partner has normal or near-normal sperm, this approach is often enough to achieve pregnancy without moving to IVF.
Success Rates Per Cycle and Over Time
The first IUI cycle tends to have the highest success rate: about 24% for clinical pregnancy per cycle. That rate dips slightly over the next two cycles, settling around 22.5% per attempt. After four cycles, cumulative rates climb to roughly 39% for clinical pregnancy and 31% for live birth.
The important pattern here is that almost all successful pregnancies happen in the first three tries. A large study of PCOS patients found that 98% of pregnancies occurred within three IUI cycles. Because of this, most fertility specialists recommend trying three cycles of IUI before considering IVF. Continuing beyond three cycles adds cost and time with very little additional chance of success.
Letrozole vs. Clomiphene for Ovulation Induction
The medication paired with IUI matters significantly. The two most common options are letrozole and clomiphene citrate, and they are not equally effective for PCOS.
Letrozole produces a live birth rate of about 25% per cycle compared to just 11% with clomiphene, a difference that held up to statistical scrutiny. Pregnancy rates followed the same pattern: 29% with letrozole versus 15% with clomiphene. Interestingly, ovulation rates were similar between the two drugs (68% vs. 64%), meaning letrozole’s advantage isn’t just about getting you to ovulate. It appears to create a better environment for implantation and early pregnancy.
Letrozole also promotes single-follicle development more reliably (77% of cycles vs. 53% with clomiphene), which reduces the risk of twins or higher-order multiples. Current international guidelines from ASRM now recommend letrozole as the first-line medication for ovulation induction in PCOS.
What a Typical IUI Cycle Looks Like
A cycle usually begins on day three of your period, either after a natural period or one triggered by progesterone. You’ll start taking oral medication (typically letrozole at 2.5 mg) for five days, beginning around cycle day three to five. If injectable hormones are needed, those also start around day three.
Monitoring begins with a baseline ultrasound on cycle day three, followed by a follicular check around days 10 to 12 to measure how your eggs are developing. After that, monitoring frequency is individualized. Some women need one additional scan, others need two or three. Your clinic is watching for at least one dominant follicle to reach about 16 mm or larger.
Once a follicle is ready, you’ll receive a trigger shot to induce ovulation. The insemination itself is scheduled about 24 to 36 hours later. The procedure takes only a few minutes, feels similar to a Pap smear for most women, and requires no anesthesia or recovery time.
How Body Weight Affects Outcomes
Weight is a common concern for women with PCOS, and the relationship with IUI outcomes is more nuanced than you might expect. A study of over 800 PCOS patients found no significant difference in clinical pregnancy rates, live birth rates, or miscarriage rates across normal weight, overweight, and obese groups.
The catch is that higher BMI does affect the treatment process itself. Overweight and obese women needed higher doses of stimulating medications and more days of monitoring before their follicles were ready. So while the end result can be similar, the path there may require more medication and patience. Higher weight also raises the risk of gestational diabetes during pregnancy, which is worth discussing with your provider regardless of how you conceive.
The Risk of Multiples
Women with PCOS are especially sensitive to ovarian stimulation, which means they’re more likely to develop multiple mature follicles in a single cycle. This raises the risk of twins or triplets. Multiple pregnancy rates during IUI range from about 3% to 8% depending on the medication used, with clomiphene carrying the highest risk (8.3%) and gonadotropins the lowest (3.3%). Letrozole falls in between at 4.1%.
The real risk factor isn’t which drug you use but how many follicles develop. Cycles where multiple follicles matured led to multiple pregnancies 15.5% of the time, compared to just 0.8% with single-follicle growth. Critically, having multiple follicles didn’t meaningfully improve live birth rates (15.8% vs. 12.7%), so the extra risk comes with almost no extra benefit. This is why careful ultrasound monitoring matters. If too many follicles develop, your clinic may recommend canceling the cycle.
PCOS also increases the baseline risk of ovarian hyperstimulation syndrome, a condition where the ovaries overreact to fertility medications and swell painfully. This is more of a concern with IVF than IUI, but your clinic will still monitor for it, particularly if you’re using injectable medications rather than oral ones.
When Sperm Quality Changes the Equation
IUI success depends on both partners. The key number is total motile sperm count after the semen sample is washed and prepared. The best pregnancy rates occur when this count falls between 5 and 10 million, with a per-cycle success rate of about 15%. Above 10 million, rates are around 11% per cycle. Below 1 million, the success rate drops to roughly 5.6%, and most specialists would not recommend IUI at that level.
Normal sperm shape (morphology of 5% or higher) also predicts better outcomes. If your partner’s semen analysis shows very low counts or poor morphology, your fertility team may suggest moving directly to IVF with sperm injection rather than spending time and money on IUI cycles unlikely to succeed.
When to Move On to IVF
The standard recommendation for PCOS patients is to try ovulation induction (with timed intercourse or IUI) before considering IVF. International guidelines suggest up to six to nine total attempts of ovulation induction before IVF, but the data specific to IUI is more focused: three cycles captures nearly all the pregnancies that IUI will produce for PCOS patients.
IVF is generally recommended when first- or second-line ovulation induction treatments have failed, or when there’s an additional fertility factor like blocked tubes, severe male factor infertility, or advanced maternal age that makes IUI unlikely to work. For women with PCOS and no other fertility issues, IUI with letrozole is a cost-effective and less invasive starting point that gives roughly one in three women a baby within a few cycles.